Search research articles
Contact Us
Filters
Showing results (481-490 of 505) with videos related to
Page
of 51
Sort By:
European Radiology
|
April 19, 2024
Re-attendance in supplemental breast MRI screening rounds of the DENSE trial for women with extremely dense breasts
Stefanie G A Veenhuizen, Sophie E L van Grinsven, Isabelle L Laseur, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
December 10, 2019
Multimorbidity in Elderly Persons According to the Year of Diagnosis of Human Immunodeficiency Virus Infection: A Cross-sectional Dat'AIDS Cohort Study
Marie Demontès, Sabrina Eymard Duvernay, Clotilde Allavena, et al.
Annales D'Endocrinologie
|
July 4, 2012
How to diagnose a lipodystrophy syndrome
Marie-Christine Vantyghem, Anne-Sophie Balavoine, Claire Douillard, et al.
Clinical Radiology
|
May 16, 2018
Reasons for (non)participation in supplemental population-based MRI breast screening for women with extremely dense breasts
S V de Lange, M F Bakker, E M Monninkhof, et al.
JCO Precision Oncology
|
December 1, 2023
Nivolumab Plus Ipilimumab in Patients With Solid Tumors With <i>ATM</i> Mutations: Results From the Targeted Agent and Profiling Utilization Registry (TAPUR) Study
Nitin Rohatgi, Michael Rothe, Pam K Mangat, et al.
JCO Precision Oncology
|
December 14, 2023
Cobimetinib Plus Vemurafenib in Patients With Solid Tumors With <i>BRAF</i> Mutations: Results From the Targeted Agent and Profiling Utilization Registry Study
Funda Meric-Bernstam, Michael Rothe, Pam K Mangat, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 15, 2024
Pertuzumab Plus Trastuzumab in Patients With Biliary Tract Cancer With <i>ERBB2/3</i> Alterations: Results From the Targeted Agent and Profiling Utilization Registry Study
Timothy L Cannon, Michael Rothe, Pam K Mangat, et al.
Journal of Hepatology
|
February 26, 2017
Efficacy and safety of direct-acting antiviral regimens in HIV/HCV-co-infected patients - French ANRS CO13 HEPAVIH cohort
Lionel Piroth, Linda Wittkop, Karine Lacombe, et al.
HIV Medicine
|
June 27, 2020
Treatment outcomes of integrase inhibitors, boosted protease inhibitors and nonnucleoside reverse transcriptase inhibitors in antiretroviral-naïve persons starting treatment
A Mocroft, B Neesgard, R Zangerle, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 10, 2023
Pembrolizumab in Patients With Tumors With High Tumor Mutational Burden: Results From the Targeted Agent and Profiling Utilization Registry Study
Herbert L Duvivier, Michael Rothe, Pam K Mangat, et al.
Page
of 51
Search research articles
Search
Showing results (481-490 of 505) with videos related to
Sort By:
Page
of 51
European Radiology
|
April 19, 2024
Re-attendance in supplemental breast MRI screening rounds of the DENSE trial for women with extremely dense breasts
Stefanie G A Veenhuizen, Sophie E L van Grinsven, Isabelle L Laseur, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
December 10, 2019
Multimorbidity in Elderly Persons According to the Year of Diagnosis of Human Immunodeficiency Virus Infection: A Cross-sectional Dat'AIDS Cohort Study
Marie Demontès, Sabrina Eymard Duvernay, Clotilde Allavena, et al.
Annales D'Endocrinologie
|
July 4, 2012
How to diagnose a lipodystrophy syndrome
Marie-Christine Vantyghem, Anne-Sophie Balavoine, Claire Douillard, et al.
Clinical Radiology
|
May 16, 2018
Reasons for (non)participation in supplemental population-based MRI breast screening for women with extremely dense breasts
S V de Lange, M F Bakker, E M Monninkhof, et al.
JCO Precision Oncology
|
December 1, 2023
Nivolumab Plus Ipilimumab in Patients With Solid Tumors With <i>ATM</i> Mutations: Results From the Targeted Agent and Profiling Utilization Registry (TAPUR) Study
Nitin Rohatgi, Michael Rothe, Pam K Mangat, et al.
JCO Precision Oncology
|
December 14, 2023
Cobimetinib Plus Vemurafenib in Patients With Solid Tumors With <i>BRAF</i> Mutations: Results From the Targeted Agent and Profiling Utilization Registry Study
Funda Meric-Bernstam, Michael Rothe, Pam K Mangat, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 15, 2024
Pertuzumab Plus Trastuzumab in Patients With Biliary Tract Cancer With <i>ERBB2/3</i> Alterations: Results From the Targeted Agent and Profiling Utilization Registry Study
Timothy L Cannon, Michael Rothe, Pam K Mangat, et al.
Journal of Hepatology
|
February 26, 2017
Efficacy and safety of direct-acting antiviral regimens in HIV/HCV-co-infected patients - French ANRS CO13 HEPAVIH cohort
Lionel Piroth, Linda Wittkop, Karine Lacombe, et al.
HIV Medicine
|
June 27, 2020
Treatment outcomes of integrase inhibitors, boosted protease inhibitors and nonnucleoside reverse transcriptase inhibitors in antiretroviral-naïve persons starting treatment
A Mocroft, B Neesgard, R Zangerle, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 10, 2023
Pembrolizumab in Patients With Tumors With High Tumor Mutational Burden: Results From the Targeted Agent and Profiling Utilization Registry Study
Herbert L Duvivier, Michael Rothe, Pam K Mangat, et al.
Page
of 51